Tp53 Y220c Mutation clinical trials

Explore recruiting tp53 y220c mutation clinical trials.

Recruiting tp53 y220c mutation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Tp53 Y220c Mutation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2 Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of PC14586 in Patients with Locally Advanced or Metastatic Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE).

Italy, Germany, France, Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Tp53 Y220c Mutation trials by city

Tp53 Y220c Mutation in Toronto Tp53 Y220c Mutation in Vancouver Tp53 Y220c Mutation in Montreal Tp53 Y220c Mutation in Calgary Tp53 Y220c Mutation in Edmonton Tp53 Y220c Mutation in Ottawa Tp53 Y220c Mutation in Winnipeg Tp53 Y220c Mutation in Quebec City Tp53 Y220c Mutation in Hamilton Tp53 Y220c Mutation in Kitchener Tp53 Y220c Mutation in London Tp53 Y220c Mutation in Halifax Tp53 Y220c Mutation in New York Tp53 Y220c Mutation in Los Angeles Tp53 Y220c Mutation in Chicago Tp53 Y220c Mutation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease